News

October 21, 2018
Not intended for U.S. and UK Media - ESMO 2018 Congress (European Society for Medical Oncology)

Expanded larotrectinib data confirm findings on efficacy and safety in adult and pediatric patients with TRK fusion cancer across various tumor types more

Up close and personal – our Scientists

Get to know Bayer’s scientists and find out more about the persons behind great innovations.

Newsletter

Our newsletter informs you regularly about news releases regarding research and innovation at Bayer.

Subscribe